Revenue |
Revenue The following table presents the Company’s disaggregated revenue by offering type (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
|
2025 |
|
2024 |
|
|
|
|
|
Total Net
Revenues
|
|
Percentage of
Total Net
Revenues
|
|
Total Net
Revenues
|
|
Percentage of
Total Net
Revenues
|
|
|
|
|
Patient Services revenue recognized at a point in time: |
|
|
|
|
|
|
|
|
|
|
|
Direct products |
$ |
638 |
|
|
1.8 |
% |
|
$ |
615 |
|
|
1.9 |
% |
|
|
|
|
Third-Party Payer products |
3,951 |
|
|
11.4 |
% |
|
1,872 |
|
|
5.9 |
% |
|
|
|
|
Patient Services revenue recognized over time: |
|
|
|
|
|
|
|
|
|
|
|
Direct rental services |
1,914 |
|
|
5.5 |
% |
|
3,572 |
|
|
11.2 |
% |
|
|
|
|
Third-Party Payer rental services |
12,215 |
|
|
35.2 |
% |
|
10,977 |
|
|
34.3 |
% |
|
|
|
|
Total Patient Services accounted for under ASC 606 |
18,718 |
|
|
53.9 |
% |
|
17,036 |
|
|
53.2 |
% |
|
|
|
|
Device Solutions revenue recognized at a point in time: |
|
|
|
|
|
|
|
|
|
|
|
Products |
4,002 |
|
|
11.5 |
% |
|
4,213 |
|
|
13.2 |
% |
|
|
|
|
Services |
2,350 |
|
|
6.8 |
% |
|
2,409 |
|
|
7.5 |
% |
|
|
|
|
Device Solutions revenue recognized over time: |
|
|
|
|
|
|
|
|
|
|
|
Services |
1,855 |
|
|
5.3 |
% |
|
1,969 |
|
|
6.2 |
% |
|
|
|
|
Total Device Solutions accounted for under ASC 606 |
8,207 |
|
|
23.6 |
% |
|
8,591 |
|
|
26.9 |
% |
|
|
|
|
Total Revenue Accounted for under ASC 606 |
26,925 |
|
|
77.6 |
% |
|
25,627 |
|
|
80.1 |
% |
|
|
|
|
Patient Services lease revenue |
2,056 |
|
|
5.9 |
% |
|
1,555 |
|
|
4.9 |
% |
|
|
|
|
Device Solutions lease revenue |
5,735 |
|
|
16.5 |
% |
|
4,813 |
|
|
15.0 |
% |
|
|
|
|
Total Revenue accounted for under ASC 842, Leases |
7,791 |
|
|
22.4 |
% |
|
6,368 |
|
|
19.9 |
% |
|
|
|
|
Total Net Revenue |
$ |
34,716 |
|
|
100.0 |
% |
|
$ |
31,995 |
|
100.0 |
% |
|
|
|
|
Contract Balances
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands) |
As of March 31, 2025 |
|
As of December 31, 2024 |
|
$ Change |
Accounts receivable, net |
$ |
23,892 |
|
|
$ |
21,155 |
|
|
$ |
2,737 |
|
Contract assets |
$ |
714 |
|
|
$ |
570 |
|
|
$ |
144 |
|
Contract liabilities |
$ |
25 |
|
|
$ |
— |
|
|
$ |
25 |
|
The change in contract assets during the three months ended March 31, 2025 included $2.4 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was fully offset by $2.3 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's condensed consolidated balance sheets.
The change in contract liabilities during the three months ended March 31, 2025 was mainly due to the increase in the value of products and services billed to customers for which control of the products and services has not transferred to the customers. Contract liabilities are included in other current liabilities on the Company's condensed consolidated balance sheets.
|